SCHEMBL8776324

SCHEMBL8776324

CC(=Cc1ccc(O)cc1)c1ccc2c(c1)C(C)(C)C(=O)C2(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
NQO2 P16083 3/20 0.51
PTGS1 P23219 3/20 0.51
PTGS2 P35354 3/20 0.51
RARB P10826 15/20 0.51
RARG P13631 15/20 0.51
RARA P10276 14/20 0.51
RXRA P19793 3/20 0.51
CYP26A1 O43174 2/20 0.51
CYP3A4 P08684 2/20 0.51
KDM4E B2RXH2 1/20 0.51
NPC1 O15118 1/20 0.51
GMNN O75496 1/20 0.51
USP2 O75604 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8776320 1.00 ESR1 (0.56) ESR1ESR2NQO2PTGS1PTGS2
SCHEMBL9859949 0.91 ESR1 (0.56) ESR1ESR2NQO2PTGS1PTGS2
SCHEMBL8522769 0.87 RARB (0.52) RARBRARGRARARXRACYP26A1
SCHEMBL8522767 0.87 RARB (0.52) RARBRARGRARARXRACYP26A1
SCHEMBL9860434 0.78 RARB (0.52) ESR1ESR2NQO2PTGS1PTGS2
SCHEMBL7223963 0.78 RARG (0.75) ESR1ESR2NQO2PTGS1PTGS2
SCHEMBL9860152 0.78 RARB (0.63) ESR1ESR2NQO2PTGS1PTGS2
SCHEMBL8776428 0.78 RARB (0.52) ESR1ESR2NQO2PTGS1PTGS2
SCHEMBL9860154 0.78 RARB (0.63) ESR1ESR2NQO2PTGS1PTGS2
SCHEMBL7223971 0.78 RARG (0.75) ESR1ESR2NQO2PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5030764-A Antitumor agents; treatment of skin disorders HOFFMANN-LA ROCHE INC. (US) 1991-07-09 US claimed
EP-0808159-A1 USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) WARNER-LAMBERT COMPANY (US) 1997-11-26 EP disclosed
WO-1996024344-A1 USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) WARNER-LAMBERT COMPANY (US) 1996-08-15 WO disclosed
US-5489611-A ADMINISTERING A RETINOID COMPOUND WARNER-LAMBERT COMPANY (US) 1996-02-06 US disclosed
US-5055622-A For treating neoplasms and dermatoses HOFFMANN-LA ROCHE INC. (US) 1991-10-08 US disclosed
US-5030764-A Antitumor agents; treatment of skin disorders HOFFMANN-LA ROCHE INC. (US) 1991-07-09 US disclosed
US-5030765-A Skin disorders, anititumor agents HOFFMANN-LA ROCHE INC. (US) 1991-07-09 US disclosed
US-5001276-A Novel tetrahydronaphthalene and indane derivatives HOFFMANN-LA ROCHE INC. (US) 1991-03-19 US disclosed
US-4990703-A Novel tetrahydronaphthalene and indane derivatives HOFFMANN-LA ROCHE INC. (US) 1991-02-05 US disclosed
US-4935560-A ANTITUMOR AGENTS; SKIN DISORDERS HOFFMANN-LA ROCHE INC. (US) 1990-06-19 US disclosed
US-4870219-A NEOPLASMS, DERMATOSES HOFFMANN-LA ROCHE INC. (US) 1989-09-26 US disclosed